miR-19a-3p inhibits invasion, migration, and osteolytic bone lesions in PCa tissues by downregulating SMAD2 and SMAD4, reducing TGF-β signaling activity [134]. The gene discussed is SMAD2; the disease is posterior cortical atrophy.